Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 28;9(5):769-791.
doi: 10.14218/JCTH.2021.00209. Epub 2021 Sep 28.

Guidelines for Prevention and Treatment of Chronic Hepatitis B

Guiqiang Wang  1 , Zhongping Duan  2
Affiliations

Guidelines for Prevention and Treatment of Chronic Hepatitis B

Guiqiang Wang et al. J Clin Transl Hepatol. .

Abstract

To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guidelines for the prevention and treatment of chronic hepatitis B (CHB). The current guidelines cover recent advances in basic, clinical, and preventive studies of CHB infection and consider the actual situation in China. These guidelines are intended to provide support for the prevention, diagnosis, and treatment of CHB.

Keywords: Chronic; Guidelines; Hepatitis B; Prevention; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests related to this publication.

Figures

Fig. 1
Fig. 1. Flow chart of antiviral therapy for patients with chronic HBV infection.
(a) Follow-up tests: virological test, liver biochemical test, AFP test, PIVKA-II test, abdominal ultrasound, and liver stiffness measurement. (b) HBV-related extrahepatic manifestations: glomerulonephritis and vasculitis. (c) Follow-up criteria for patients with HBV-related decompensated cirrhosis during NA treatment: perform a routine blood test, liver biochemical test, renal function test, virological test, and test for blood ammonia, AFP, and PIVKA-II, and abdominal ultrasound every 3 months. If necessary, perform enhanced CT or MRI. (d) Other causes of ALT elevation: infection by other pathogens, history of drug or poison use, history of alcohol use, lipid metabolism disorders, autoimmune disorders, liver congestion or vascular diseases, inherited metabolic liver disease, systemic diseases. (e) NAs-ETV, TDF, TAF. HbsAg, hepatitis B surface antigen; HBV, hepatitis B virus; ALT, alanine aminotransferase; HCC, hepatocellular carcinoma; NAs, nucleos(t)ide analogs; peg-IFN-α, pegylated interferon-α.
See this image and copyright information in PMC

References

    1. WHO. Global hepatitis report 2017. Available from: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
    1. Cui F, Shen L, Li L, Wang H, Wang F, Bi S, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi: 10.3201/eid2305.161477. - DOI - PMC - PubMed
    1. Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230–238. doi: 10.2471/blt.18.219469. - DOI - PMC - PubMed
    1. Xu Y, Liu H, Wang Y, Hao R, Li Z, Song H. The next step in controlling HBV in China. BMJ. 2013;347:f4503. doi: 10.1136/bmj.f4503. - DOI - PubMed
    1. Lu Y, Zhu FC, Liu JX, Zhai XJ, Chang ZJ, Yan L, et al. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: a large prospective cohort study in China. Vaccine. 2017;35(48):6627–6633. doi: 10.1016/j.vaccine.2017.10.032. - DOI - PubMed